Treatment Of Cognitive deficits in schizophrenia with Tolcapone And Pergolide
Completed
- Conditions
- Schizophrenia, cognitive functionsSchizophreniaMental and Behavioural Disorders
- Registration Number
- ISRCTN42412532
- Lead Sponsor
- RWTH Aachen University (Germany)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1. 60 patients suffering from schizophrenia using Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria
2. Signed informed consent
3. Aged 18 - 55 years, either sex
4. Negative pregnancy test
5. No drug addiction
6. No suicidality
7. Ability to understand and read German language
Exclusion Criteria
1. Drug addiction
2. Severe medical problems
3. Long-QT-syndrome
4. Problems regarding the heart-valves
5. Seizures
6. Reduced liver or renal function
7. Pregnancy
8. Known incompatibility of the study-drugs
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method